SEC Form 4 research
| Issuer | Entrada Therapeutics, Inc. |
|---|---|
| Tickers | TRDA |
| Reporting owners | 41 |
| Officers and directors | 8 |
| Last public filing | 2026-09-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-09 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 28,837 | $7.13 | Not reported |
| 2026-09-09 | 2026-09-08 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 192,500 | $7.41 | Not reported |
| 2026-09-09 | 2026-09-04 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 38,500 | $7.11 | Not reported |
| 2026-09-09 | 2026-09-09 | EVNIN LUKE, Foley Todd, GADICKE ANSBERT, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P. | S | 28,837 | $7.13 | Not reported |
| 2026-09-09 | 2026-09-08 | EVNIN LUKE, Foley Todd, GADICKE ANSBERT, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P. | S | 192,500 | $7.41 | Not reported |
| 2026-09-09 | 2026-09-04 | EVNIN LUKE, Foley Todd, GADICKE ANSBERT, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P. | S | 38,500 | $7.11 | Not reported |
| 2026-09-03 | 2026-09-03 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 32,263 | $7.17 | Not reported |
| 2026-09-03 | 2026-09-02 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 25,131 | $7.19 | Not reported |
| 2026-09-03 | 2026-09-01 | MPM BIOVENTURES 2018, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC | S | 29,088 | $7.06 | Not reported |
| 2026-09-03 | 2026-09-03 | EVNIN LUKE, Foley Todd, GADICKE ANSBERT, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P. | S | 32,263 | $7.17 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.